bluebird bio, Inc.
SICKLE CELL POTENCY ASSAY

Last updated:

Abstract:

Disclosed herein are potency assays for a gene therapy treatment for sickle cell disease. Also disclosed herein are methods for measuring relative potency of a drug product used for the treatment of sickle cell disease.

Status:
Application
Type:

Utility

Filling date:

20 Mar 2020

Issue date:

19 May 2022